Your browser doesn't support javascript.
loading
FOXO transcriptional activity is associated with response to chemoradiation in EAC.
Creemers, A; van der Zalm, A P; van de Stolpe, A; Holtzer, L; Stoffels, M; Hooijer, G K J; Ebbing, E A; van Ooijen, H; van Brussel, A G C; Aussems-Custers, E M G; van Berge Henegouwen, M I; Hulshof, M C C M; Bergman, J J G H M; Meijer, S L; Bijlsma, M F; van Laarhoven, H W M.
  • Creemers A; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van der Zalm AP; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • van de Stolpe A; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Holtzer L; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Stoffels M; Philips Molecular Pathway Diagnostics, Eindhoven, The Netherlands.
  • Hooijer GKJ; Philips Molecular Pathway Diagnostics, Eindhoven, The Netherlands.
  • Ebbing EA; Philips Research, Eindhoven, The Netherlands.
  • van Ooijen H; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Brussel AGC; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Aussems-Custers EMG; Philips Research, Eindhoven, The Netherlands.
  • van Berge Henegouwen MI; Philips Molecular Pathway Diagnostics, Eindhoven, The Netherlands.
  • Hulshof MCCM; Philips Research, Eindhoven, The Netherlands.
  • Bergman JJGHM; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Meijer SL; Department of Radiotherapy, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bijlsma MF; Department of Gastroenterology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Laarhoven HWM; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
J Transl Med ; 20(1): 183, 2022 04 25.
Article en En | MEDLINE | ID: mdl-35468793
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article